John Mendelsohn, MD, President of the University of Texas M. D. Anderson Cancer Center has been selected to receive the 27th Annual Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research. He was recognized for his long-time leadership role in cancer education, research, and treatment and for his pivotal discoveries in inhibiting cell growth. For example, he was the first to conceptualize that therapeutic agents could block the activation of specific receptors on the surface of cells that control cancer cell proliferation and function, leading to the development of targeted cancer therapies. One of those, now known as cetuximab (Erbitux), derived from monoclonal antibody 225, was approved in February for the treatment of patients with EGFR-expressing metastatic colorectal cancer who are intolerant to irinotecan-based chemotherapy. The drug is being jointly developed by ImClone and Bristol-Myers Squibb. A news release from the company noted that Dr. Mendelsohn's selection was made by an independent panel and that Bristol-Myers Squibb takes no active role in the process. The award, a $50,000 cash prize and a silver commemorative medallion, will be officially presented at the annual Bristol-Myers Squibb Distinguished Achievement Award Dinner to be held in New York City in October
David Spriggs, MD, has been appointed Head of the Division of Solid Tumor Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Spriggs joined MSKCC in 1993 as Chief of Developmental Chemotherapy and was named to the Winthrop Rockefeller Chair in Medical Oncology in 2001.
Moon S. Chen, Jr., PhD, MPH, Professor of Epidemiology and Preventive Medicine at the University of California Davis School of Medicine and Medical Center and Head of the UC Davis Cancer Center's Cancer Control and Prevention Program, has received the American Cancer Society's Humanitarian Award. Dr. Chen was honored for his “unfailing commitment and considerable contributions to the field of public health,” particularly dedication to addressing and improving the health of Asian Americans and Pacific Islanders and “leadership in investigating and securing funds for continued research focusing on the health disparities within minority populations.”
The University of Texas Health Science Center at San Antonio and the Cancer Therapy and Research Center (CTRC) has announced a change in leadership of the San Antonio Cancer Institute (SACI). David H. Boldt, MD, Professor of Medicine and Chief of the Hematology Division in the Department of Medicine at the Health Science Center since 1985, has been named SACI Interim Director. Charles A. Coltman, Jr., MD, Director of the Institute since its inception, will remain as Senior Advisor to Dr. Boldt. Dr. Boldt called Dr. Coltman a terrific and effective leader, and said, “We have benefited from his wisdom.”
Sunil J. Panchal, MD, Former Director of both the Division of Pain Medicine, and the Quadri-Institutional Pain Medicine Fellowship at Weill Medical College of Cornell University, New York Presbyterian Hospital has been appointed Director of Interventional Pain Management, at H. Lee Moffitt Cancer Center & Research Institute.
The AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta has named Bradley George, MD, as Medical Director at Children's at Scottish Rite. Dr. George is a pediatric oncologist specializing in clinical care and research for high-risk solid tumors.
Agustin Garcia, MD, has been appointed Director of Breast Cancer Research at the Women's Cancer Research Institute at Cedars-Sinai Medical Center. He previously served as Director of the Clinical Investigation Support Office at the University of Southern California Norris Comprehensive Cancer Center.
Awards Presented by Cancer Research and Prevention Foundation
The Cancer Research and Prevention Foundation presented Cancer Prevention Laurels, named after the ancient Roman symbol of tribute, honor, victory, merit, and reward. to the following seven individuals, honored for their work in advancing colorectal cancer research and prevention:
© 2004 Lippincott Williams & Wilkins, Inc.
- ▪ Nathaniel Cobb, MD, Director of Cancer Prevention and Control for the Indian Health Service and Acting Chief Medical Officer for IHS Headquarters West, for dedication to public service.
- ▪ Amelie Ramirez, DrPH, Associate Professor of Medicine and Deputy Director of the Chronic Disease Prevention and Control Research Center at Baylor College of Medicine, for dedication to community programs.
- ▪ Robert A. Smith, PhD, Cancer Epidemiologist and Director of Cancer Screening at the National Office of the American Cancer Society, for national leadership.
- ▪ Cindy Iverson, Development Director for the Minnesota Colon and Rectal Foundation, for advocacy.
- ▪ Meinhard Classen, MD, President of the World Organization of Gastroenterology, Co-Chair of the International Digestive Cancer Alliance and Past President of the World Gastroenterology Organization (OMGE), for international leadership.
- ▪ Paul Rozen, MD, Chairman of the World Organization for Digestive Endoscopy, Staff Member in the Department of Gastroenterology at Tel Aviv Medical Center, Professor of Medicine at Tel Aviv University and Member of the International Digestive Cancer Alliance, for international leadership.
- ▪ Sydney J. Winawer, MD, Paul Sherlock Chair at Memorial Sloan-Kettering Cancer Center, Co-Chair of the International Digestive Cancer Alliance, and Chairman of the New York City Colorectal Cancer Awareness Campaign, for international leadership.
More on ONCOLOGY-TIMES.com...